Botanical Solution Inc. Obteve $7,6 milhões em extensão da Série A
20/08/2024
Botanical Solution Inc. secures $7.6 million to begin in-house production of QS-21, a sustainable vaccine adjuvant derived from plant tissue culture.
Botanical Solution
Botanical Solution, Inc. Secures Additional $7 Million, Totaling Over $13 Million in Series A Funding
24/08/2023
Botanical Solution Inc. (BSI), a company specializing in sustainable and cost-effective Advanced Botanical Materials, has successfully secured an additional $7 million in funding. This latest